Farallon Capital Management LLC Seagen Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.0 - $228.9 $0 - $520 Million	-2,270,500 Closed	0 $0
Q3 2023 Feb 14, 2024	BUY	$191.51 - $216.16 $301 Million - $339 Million	1,570,500 Added 224.36%	2,270,500 $482 Million
Q2 2023 Feb 14, 2024	BUY	$187.64 - $206.25 $89.1 Million - $98 Million	475,000 Added 211.11%	700,000 $135 Million
Q1 2023 Feb 14, 2024	BUY	$127.59 - $203.08 $28.7 Million - $45.7 Million	225,000 New	225,000 $45.6 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.